Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo

"[P]eople acting in a group can accomplish things which no individual acting alone could even hope to bring about." - FDR

Home :  Regulatory Policy :  RegWatch : 
RegWatch:     

News & Analysis | REG•WATCH Blog | Press Room

 R    E    G    •    W    A    T    C    H 


Tuesday, May 01, 2007

"Calling All Germane Amendments!": PDUFA Negotiation in the Senate

Senate leaders on food and drug regulation continue to wrangle over provisions of the reauthorization of the Prescription Drug User Fee Act (PDUFA). A Senate Committee reported PDUFA to the Senate floor two weeks ago.

Because PDUFA expires in September, and because the funds it provides FDA are necessary for the agency to operate, the reauthorization legislation is considered a must pass. That makes it a golden opportunity for Senators to attach all sorts of additional provisions.

The most contentious thus far has been a proposal to give FDA the authority to approve generic drugs. The pharmaceutical industry opposes such a provision (surprise!), and, according to the National Journal (subscription) has the support of Senate Majority Leader Harry Reid. A provision for generic drugs would likely offer consumers more generic drug choices and lower prices. Sens. Ted Kennedy, Hillary Clinton, and Chuck Schumer are pushing for a generics provision. What is Harry Reid's deal?

Other additions include a moratorium on direct-to-consumer advertising for risky drugs, the creation of a single food safety monitoring agency (currently the duties are split among several bodies including FDA and USDA) and increased pet food safety monitoring, all according to the National Journal.



Posted by Matt Madia



Entries by Theme

All Themes

Enforcement

About This Blog

Rollbacks

Safety

Industry Influence

Cost-Benefit Analysis

In Congress

Publications

Consumer Issues

Environment

Public Health

In the Courts

Oversight

In the White House

Most Recent Entries for RegWatch

Bush Administration Backs Off SCHIP Restrictions

Bush Signs Consumer Product Safety Bill

Bush Administration Cuts Habitat for Spotted Owl

Bush Trying Last-Minute Changes to Endangered Species Act

For EPA Staff Trying to Protect the Planet, "Disappointment is Profound"

Consumer Product Bill Delivers Win for Consumers

Will New FDA Guidelines Really Reduce Conflicts of Interest?

Crane Rule Held Back by Bush Administration Ideology

Senate Passes Product Safety Bill

Product Safety Bill Overwhelmingly Approved by House

Archived Entries for Consumer Issues

August

July

May

April

March

February

January

December, 2007

November, 2007

October, 2007

September, 2007

August, 2007

July, 2007

June, 2007

May, 2007

April, 2007

March, 2007

February, 2007

January, 2007

December, 2006

November, 2006

October, 2006

September, 2006

August, 2006

May, 2006

April, 2006

February, 2006

January, 2006

December, 2005

November, 2005

October, 2005

September, 2005

August, 2005

July, 2005

June, 2005

May, 2005

April, 2005

March, 2005

February, 2005

January, 2005

December, 2004

November, 2004

October, 2004

September, 2004